Assenagon Asset Management
CLSD

Assenagon Asset Management’s Clearside Biomedical CLSD Stock Holding History

Assenagon Asset Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,794
Closed -$106K – 1189
2025
Q2 		$106K Hold
8,794
– – ﹤0.01% 1136
2025
Q1 		$121K Hold
8,794
– – ﹤0.01% 1126
2024
Q4 		$125K Sell
8,794
-8,346
-49% -$137K ﹤0.01% 1291
2024
Q3 		$327K Sell
17,140
-1,740
-9% -$29.7K ﹤0.01% 1290
2024
Q2 		$368K Buy
+18,880
New +$365K ﹤0.01% 1288
2023
Q4 		– Sell
-4,785
Closed -$62.4K – 1415
2023
Q3 		$62.4K Hold
4,785
– – ﹤0.01% 1364
2023
Q2 		$80.4K Sell
4,785
-5,324
-53% -$91.7K ﹤0.01% 1301
2023
Q1 		$158K Sell
10,109
-1,063
-10% -$20.6K ﹤0.01% 1373
2022
Q4 		$188K Sell
11,172
-16,207
-59% -$292K ﹤0.01% 1317
2022
Q3 		$464K Sell
27,379
-23,034
-46% -$505K ﹤0.01% 1111
2022
Q2 		$1.11M Sell
50,413
-10,506
-17% -$255K ﹤0.01% 1047
2022
Q1 		$2.09M Sell
60,919
-48,042
-44% -$1.44M 0.01% 827
2021
Q4 		$4.5M Buy
108,961
+107,703
+8,561% +$6.98M 0.01% 550
2021
Q3 		$113K Buy
+1,258
New +$111K ﹤0.01% 1258
2021
Q2 		– Sell
-8,088
Closed -$300K – 1233
2021
Q1 		$300K Buy
+8,088
New +$406K ﹤0.01% 1101

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Assenagon Asset Management's CLSD Position: Q3 2025 in Review

Assenagon Asset Management sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 8,794 shares — an estimated $106K sold.

Assenagon Asset Management first reported a position in CLSD in Q1 2021 and held it in 15 quarters. The position peaked at $4.5M in Q4 2021. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Assenagon Asset Management reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Assenagon Asset Management sold 8,794 Clearside Biomedical shares in Q3 2025, an estimated $106K.
  • Assenagon Asset Management first reported a position in Clearside Biomedical in Q1 2021 and held it in 15 quarters.
  • Assenagon Asset Management's Clearside Biomedical position peaked at $4.5M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Assenagon Asset Management's 13F filing for Q3 2025, filed 7 Oct 2025.